Does DIGOXIN Cause Interstitial lung disease? 26 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Interstitial lung disease have been filed in association with DIGOXIN (Digoxin). This represents 0.3% of all adverse event reports for DIGOXIN.
26
Reports of Interstitial lung disease with DIGOXIN
0.3%
of all DIGOXIN reports
3
Deaths
25
Hospitalizations
How Dangerous Is Interstitial lung disease From DIGOXIN?
Of the 26 reports, 3 (11.5%) resulted in death, 25 (96.2%) required hospitalization, and 2 (7.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DIGOXIN. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does DIGOXIN Cause?
Toxicity to various agents (1,371)
Bradycardia (896)
Dyspnoea (762)
Nausea (762)
Vomiting (715)
Acute kidney injury (708)
Fatigue (638)
Dizziness (616)
Diarrhoea (607)
Drug ineffective (568)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which DIGOXIN Alternatives Have Lower Interstitial lung disease Risk?
DIGOXIN vs DIHYDRALAZINE
DIGOXIN vs DIHYDROCODEINE
DIGOXIN vs DIHYDROERGOTAMINE
DIGOXIN vs DILANTIN
DIGOXIN vs DILANTIN-125